occurring in the province of Ontario from 2005 to 2014. Surgeon annual volume was classified by quintiles, with the highest annual volume acting as the reference category for the analysis. Multivariable logistic regression modeling was used, adjusting for patient factors (age, sex, comorbidities, year of procedure, income), surgeon years of experience and clustering amongst institutions, to investigate the relationship between surgeon annual volume and 30-day mortality, 30-day complications (myocardial infarction, stroke, hemorrhage, infection, pneumonia, deep vein thrombosis/pulmonary embolism, acute renal failure), 30-day reoperations (related to index procedure), 1-year mortality, and 1-year reoperations. The potential effects of annual surgeon composite volume and surgeon years of experience on postoperative outcomes were also explored.
Objectives: The 2010 Endovascular Aortic Repair-2 Trial (EVAR-2) reported that patients with comorbidity profiles rendering them unfit for open aneurysm repair who underwent endovascular aortic repair (EVAR) did not result in a survival advantage compared those who did not undergo intervention. These patients experienced a 30-day mortality of 7.3%, while reports from similar cohorts report far lower mortality rates. The primary objective of our study was to compare the incidence of 30-day mortality in low-and high-risk patients undergoing EVAR in a contemporary dataset, using patient risk stratification criteria from EVAR-2. Secondarily, we sought to identify risk factors associated with a disproportionate contribution to 30-day mortality risk.
Methods: Data was obtained from the 2005 to 2013 American College of Surgeons National Surgical Quality Improvement Program participant user files (n ¼ 24,813). Patients were included in the high-risk cohort with the presence of renal, respiratory, or cardiac preoperative criteria alone or in combination. Renal criteria were defined as dialysis, or creatinine >2.26 mg/dL. Respiratory criteria included history of chronic obstructive pulmonary disease, or preoperative ventilator support. Cardiac criteria included history of myocardial infarction, congestive heart failure, angina, or prior coronary intervention. Patient, procedural characteristics and 30-day postoperative outcomes were compared using Pearson c 2 tests for categoric variables and Wilcoxon rank sum tests for continuous variables.
Results: Among 24,813 patients undergoing EVAR, 12,031 patients (48%) were characterized as high-risk while 12,770 patients (52%) were stratified as low-risk. Thirty-day mortality rate in the high-risk cohort was 1.9%, compared to the 7.3% reported by EVAR-2, and higher in the high-risk cohort compared to the low-risk cohort (1.9% vs 0.9%; P < .001). While the presence of each comorbidity increased the odds of 30-day mortality (respiratory: odds ratio [OR], 1.62; 95% confidence interval [CI], 1.16-2.26; P ¼ .005; cardiac: OR, 1.55; 95% CI, 1.14-2.10; P ¼ .005), the presence of renal criteria disproportionately increased the odds of mortality threefold (OR, 3.42; 95% CI: 2.31-5.09; P < .001). Thirty-day mortality rates compounded with increasing numbers of comorbidities: patients with one comorbidity criterion experienced a 1.6% 30-day mortality, up to 8.7% in patients meeting three criteria (P < .001).
Conclusions: Contemporary 30-day mortality following EVAR in highrisk patients is substantially lower than that reported in the EVAR-2 trial. While low-and high-risk stratification by current comorbidity criteria is appropriate, attention needs to be paid to disproportionate risk contribution from renal disease on mortality compared to cardiac and pulmonary comorbidities. Given the lower mortality risk than previously described, patients stratified as high-risk should be thoughtfully considered for definitive endovascular aneurysm repair.
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Challenging Iliac Anatomy in Fenestrated Endovascular Aortic Aneurysm Repair Objectives: Fenestrated/branched endovascular repair (F/BEVAR) is a complex procedure that can be complicated, prolonged, and/or aborted due to difficult access vessel issues. Specifically, patients with significant aortoiliac occlusive disease, pre-existing endografts, and/or unilateral iliac occlusion represent a unique cohort with limited data regarding outcomes after F/BEVAR. This study describes our experience with challenging iliac anatomy in F/BEVAR patients.
Methods: A retrospective analysis of a prospectively maintained F/BEVAR database was performed on all procedures from 2009 to 2016. Operative details, including access vessel delivery approach, adjunct procedures, open/endovascular conduit use, and device configuration was abstracted. Challenging iliac anatomy was defined by use of open/ endoconduit, preemptive iliac angioplasty, aortouniiliac devices, and/or a Data are presented as number (%) or mean 6 standard deviation.
single-side access. Procedure details and outcomes were compared to patients with standard iliac anatomy not requiring these interventions.
Results: A total of 322 patients underwent F/BEVAR, and difficult iliac access was present in 57 (18%). Iliac conduits were used in 38 (12%; open conduit, n ¼ 31; endoconduit, n ¼ 9). Endoconduits included 8-to 14-mm Cook Zilver stents and 10-mm Viabahn stent grafts implanted prior to device delivery. Open conduits were 10-mm Dacron iliofemoral bypasses (n ¼ 28) or aortofemoral bypasses (n ¼ 3). Three patients had both an endoconduit and an open conduit (ipsilateral stent grafting, iliofemoral bypass contralaterally), and eight had bilateral endoconduits. In an additional 12 patients (4%), serial balloon angioplasty was performed to facilitate device delivery. There were seven staged procedures in the open conduit cohort whereby the conduit was constructed and a proximal thoracic stent graft was deployed, followed by F/BEVAR as a second procedure. There were 11 patients (3%) with single-vessel access for device deployment and branch vessel cannulation. Ten patients (3%) received an aortouniiliac F/BEVAR device configuration, with two having pre-existing femoral-femoral crossover bypass and eight undergoing new femoral-femoral crossover bypass. When compared to those with standard iliac anatomy, difficult iliac access cases had higher proportion of female patients and greater likelihood of thoracoabdominal aneurysm as a preoperative indication (Table) . Notably, estimated blood loss, procedure time, and length of stay were higher in challenging iliac anatomy patients. 30-day mortality and postoperative complications were similar.
Conclusions: Patients with difficult iliac access can successfully undergo F/BEVAR with careful preoperative planning without a substantial increase in morbidity or mortality. Not surprisingly, these patients have longer operative times and increased LOS; however, this challenging subset of patients should not be excluded from consideration of F/BEVAR. Objectives: A significant number of patients suffering ruptured abdominal aortic aneurysms (RAAA) present to facilities lacking means of definitive management. Given the mortality and morbidity of untreated RAAA, these patients require resuscitation and transfer to tertiary referral centers for definitive surgery and postoperative care. As a tertiary referral center, we sought to evaluate the outcomes of patients being transferred by either ground ambulance or Flight-For-Life (FFL) vs those patients who present directly to the treating hospital.
Methods: A retrospective review was performed of patients presenting to, or transferred to, a tertiary referral hospital between 1998 and 2015. Main outcomes were survival, ventilation days, intensive care unit days, and length of stay. Comparisons were made using the c 2 test, t-test, and Wilcox rank sum test. Survival estimates were calculated using the Kaplan-Meier method and compared using the log-rank test.
Results: There were 160 patients identified in whom open or endovascular repair of a RAAA was attempted: 44% (n ¼ 71) presented directly to the emergency department, 26% were transferred by ground (n ¼ 41), and 30% (n ¼ 48) were transferred by FFL. Patients presenting directly to the tertiary center had a lower admitting systolic blood pressure (P < .001), decreased time to operation (P < .001), and lower 24-hour mortality (P ¼ .012). Mean distance traveled was 34.48 6 35.96 for ground transport and 49.37 6 37.02 miles for FFL. Time to operation was longer in the ground transport when compared to FFL (251.35 6 269.22 vs 161.29 6 158.81 minutes). There was no difference in 30-day (P ¼ .070), 6-month (P ¼ .192), or 12-month (P ¼ .305) survival between the three groups.
Conclusions: Patients transferred by ground or by FFL to a tertiary referral center for repair of RAAA do not experience increased mortality compared to patients presenting directly to the tertiary center. Prompt recognition and transfer of patients by the referring center, and wellorganized advanced life support transport services, are critical components of this process. Regionalization of care appears to be a feasible strategy for the management of ruptured aortic aneurysms. Objectives: Differences in pathophysiology, anatomy, operative approach, indication for repair, and outcomes of abdominal aortic aneurysms (AAAs) have been described for women vs men. Women with AAA exhibit more rapid aneurysm growth and greater rupture risk at equivalent diameters. Evidence suggests that biomechanical peak wall stress (PWS) derived from finite-element analysis (FEA) of AAAs is a superior predictor of clinical outcomes compared to maximum transverse diameter (MTD). The goal of this study was to investigate differences in the calculated PWS of AAAs between men and women.
Methods: A total of 35 men and 35 women with infrarenal AAAs with 45-55 mm MTD undergoing computed tomography angiography were identified. Customized image processing algorithms extracted patientspecific AAA geometries from raw Digital Imaging and Communications in Medicine images. The resulting aortic reconstructions incorporated patient-specific and regionally resolved aortic wall thickness, intraluminal thrombus, and wall calcifications. Aortic computational models were loaded with 120 mm Hg blood pressure using commercially available finite-element analysis solvers.
Results: No significant differences were found between men and women's maximum transaortic diameters (50.5 6 3.1 vs 49.8 6 2.9 mm; P ¼ .34). PWS was found to be significantly higher in women (299 6 51 vs 257 6 53 kPA; P ¼ .001, Fig) . This difference persisted when PWS was normalized by diameter (6.0 6 1.1 vs 5.2 6 1.1 kPa/mm; P ¼ .001). Neither mean aortic wall thickness (2.38 6 0.52 vs 2.34 6 0.50 mm; P ¼ .69) nor wall thickness at location of PWS (2.36 6 0.60 vs 2.20 6 0.46 mm; P ¼ .20) varied by sex. While there were no sex-associated differences in aneurysm volume (86.6 6 27.0 vs 94.8 6 25.5 cm 3 ; P ¼ .76) or intraluminal thrombus volume (14.2 6 11.7 vs 16.3 6 13.4 cm 3 ; P ¼ .33), women's AAAs had significantly increased maximum Gaussian curvature (0.032 6 0.011 vs 0.025 6 0.015 mm -2 ; P ¼ .03). Conclusions: Comparably sized AAAs in women have significantly higher PWS. No significant differences were found in wall thickness, aneurysm volume, or thrombus volume, suggesting that morphological differences account for most of the disparity in PWS. Maximum Gaussian curvature, a measure of aneurysm morphology, was significantly different between the two groups. These results suggest that men and women possess distinct aneurysm geometries and that PWS-derived rupture risk prediction may be a more reliable estimator of rupture risk than MTD in all patients. 
